Skip to main content
. 2023 Aug 31;2023(8):CD013074. doi: 10.1002/14651858.CD013074.pub2

ACTRN12618000724279.

Study name Evaluation of the effectiveness of home‐base physical training in patients undergoing haemodialysis
Methods Study design
  • RCT

  • Duration of follow‐up: 6 months

Participants Study characteristics
  • Country: Poland

  • Setting: not reported

  • Inclusion criteria

    • Adults suffering from ESKD, treated by HD for at least 3 months

    • No contraindications to physical training

    • Giving informed written consent

  • Exclusion criteria

    • Lack of logical contact

Interventions Intervention group
  • Home‐based physical training with recommended frequency 3 times/week on days without dialysis treatment. Every training session lasts 30 minutes (3 times at 10‐minute intervals)


Control group
  • Non‐training group


Co‐interventions
  • Not reported

Outcomes Planned outcomes
  • Fatigue

    • Borg scale (Rate of Perceived Exertion scale) (≤ 3 on 0‐10 scale): after 6 months

    • FACIT Fatigue Scale: after 6 months

  • Assessment of exercise tolerance: after 6 months

  • Functional fitness

    • Fullerton Test: after 6 months

  • Quality of life

    • KDQOL‐SF TM: after 6 months

  • Physical function

    • 6MWT: after 6 months

  • Peripheral BP: after 6 months

  • Physical activity

    • IPAQ: after 6 months

  • BIA: after 6 months

  • Independence in activities of daily living

    • Katz index: after 6 months

  • Independence of instrumental activities of daily living

    • Lawton Index: after 6 months

  • Hand grip strength: after 6 months

  • Lower extremities strength

    • Sit to Stand to Sit Test: after 6 months

  • Change in rheologic properties of blood composite of AI‐ aggregation of RBC index: after 6 months

  • EI‐ elongation of RBC index: after 6 months

  • Change in biochemical profile composite of tNO3, fibrinogen and Irisin: after 6 months

  • Haematological parameters (Hb, HCT, erythrocytes leukocyte count platelet count): after 6 months

  • Assessment of heart structure and function (mitral valve medium and maximum pressure gradient, E/A ratio, right ventricular systolic pressure, left ventricular end‐systolic and end‐systolic diameter, intra‐ventricular septal thickness (IVS) during systole and diastole, left ventricular posterior wall during systole and diastole, left and right atrial size: after 6 months

  • Levels of calcium, phosphorous, potassium, sodium, albumin, urea, creatinine: after 6 months

Starting date August 2015
Contact information Katarzyna Chojak‐Fijalka
Phone: +48 683 11 24
Email: katarzyna.chojak@awf.krakow.pl
Notes ClinicalTrials.gov Identifier: ACTRN12618000724279. Funding: University of Physical Education in Cracow. Recruitment status: completed